About Amgen (AMGN)
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis... Read more
- USD273.16
- USD280.00
- USD272.28
- USD346.85
- -15.30%
- 32.5B
- 3.22M
- 4.77M
- 152.1B
- 257.80
- 1.20%
- 13.30%
Stock News
4 hours ago
3 Top Stocks to Buy This Holiday Season
Yahoo
4 hours ago
Nippon Steel Makes Final Push to Win Over US Workers
Yahoo
4 hours ago
Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition
Yahoo
5 hours ago
Legal Hurdles Can’t Slow Down Alphabet’s (GOOG) Growth
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
